1-2-dioleoyloxy-3-(trimethylammonium)propane and Constriction--Pathologic

1-2-dioleoyloxy-3-(trimethylammonium)propane has been researched along with Constriction--Pathologic* in 1 studies

Other Studies

1 other study(ies) available for 1-2-dioleoyloxy-3-(trimethylammonium)propane and Constriction--Pathologic

ArticleYear
Inhibition of vein graft stenosis with a c-jun targeting DNAzyme in a cationic liposomal formulation containing 1,2-dioleoyl-3-trimethylammonium propane (DOTAP)/1,2-dioleoyl-sn-glycero-3-phosphoethanolamine (DOPE).
    International journal of cardiology, 2013, Oct-09, Volume: 168, Issue:4

    Coronary artery bypass grafting (CABG) is among the most commonly performed heart surgical procedures. Saphenous vein graft failure due to stenosis impedes the longer-term success of CABG. A key cellular event in the process of vein graft stenosis is smooth muscle cell hyperplasia. In this study, we evaluated the effect of a DNAzyme (Dz13) targeting the transcription factor c-Jun in a rabbit model of vein graft stenosis in a cationic liposomal formulation containing 1,2-dioleoyl-3-trimethylammonium propane (DOTAP)/1,2-dioleoyl-sn-glycero-3-phosphoethanolamine (DOPE). Dz13 in DOTAP/DOPE has undergone preclinical toxicological testing, and a Phase I clinical trial we recently conducted in basal cell carcinoma cancer patients demonstrates that it is safe and well tolerated after local administration.. Effects of Dz13 in a formulation containing DOTAP/DOPE on smooth muscle cell (SMC) growth and c-Jun expression were assessed. Dz13 transfection was determined by cellular uptake of carboxyfluorescein-labeled Dz13. Autologous jugular vein to carotid artery transplantation was performed in New Zealand White rabbits to investigate the effect of the Dz13 in DOTAP/DOPE formulation on intimal hyperplasia.. Dz13/DOTAP/DOPE reduced SMC proliferation and c-Jun protein expression in vitro compared with an impotent form of Dz13 bearing a point mutation in its catalytic domain (Dz13.G>C). The Dz13(500 μg)/DOTAP/DOPE formed lipoplexes that were colloidally stable for up to 1h on ice (0°C) and 30 min at 37°C, allowing sufficient uptake by the veins. Dz13 (500 μg) inhibited neointima formation 28 d after end-to-side transplantation.. This formulation applied to veins prior to transplantation may potentially be useful in efforts to reduce graft failure.

    Topics: Animals; Cations; Cells, Cultured; Chemistry, Pharmaceutical; Constriction, Pathologic; DNA, Catalytic; Fatty Acids, Monounsaturated; Graft Rejection; JNK Mitogen-Activated Protein Kinases; Jugular Veins; Liposomes; Male; Phosphatidylethanolamines; Quaternary Ammonium Compounds; Rabbits; Vascular Grafting

2013